Q1 2019 13F Holders as of 3/31/2019
-
Type / Class
-
Equity / Class B Common Stock
-
Shares outstanding
-
5.07M
-
Number of holders
-
336
-
Total 13F shares, excl. options
-
19.4M
-
Shares change
-
-252K
-
Total reported value, excl. options
-
$5.92B
-
Value change
-
+$30.2M
-
Put/Call ratio
-
1.05
-
Number of buys
-
187
-
Number of sells
-
-143
-
Price
-
$305.68
Significant Holders of BIO-RAD LABORATORIES, INC. - Class B Common Stock (BIO) as of Q1 2019
388 filings reported holding BIO - BIO-RAD LABORATORIES, INC. - Class B Common Stock as of Q1 2019.
BIO-RAD LABORATORIES, INC. - Class B Common Stock (BIO) has 336 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 19.4M shares
.
Largest 10 shareholders include BlackRock Inc. (1.93M shares), VANGUARD GROUP INC (1.92M shares), AMERICAN CENTURY COMPANIES INC (789K shares), ATLANTA CAPITAL MANAGEMENT CO L L C (750K shares), WELLS FARGO & COMPANY/MN (630K shares), Levin Easterly Partners LLC (587K shares), ACADIAN ASSET MANAGEMENT LLC (513K shares), STATE STREET CORP (490K shares), MILLENNIUM MANAGEMENT LLC (421K shares), and Russell Investments Group, Ltd. (396K shares).
This table shows the top 336 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.